Michael A. Thompson

Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses challenges facing the field of multiple myeloma.

There has been an increase in the amount of drugs available for patients with multiple myeloma, but now there is the challenge of determining successful combinations, sequencing these new agents, and the costs, states Thompson.

As patients are living longer, there are certain patients experiencing central nervous system (CNS) involvement with myeloma and more extramedullary disease, both of which were previously rare in multiple myeloma.

Author | Michael A. Thompson

Articles

Dr. Thompson on Challenges Facing the Field of Multiple Myeloma